Brand names: Moviprep
Contraindications
4 CONTRAINDICATIONS MoviPrep is contraindicated in the following conditions: • Gastrointestinal (GI) obstruction [see Warnings and Precautions (5.6) ] • Bowel perforation [see Warnings and Precautions (5.6) ] • Gastric retention • Ileus • Toxic colitis or toxic megacolon • Hypersensitivity to any ingredient in MoviPrep [see Warnings and Precautions (5.10) and Description (11) ] • Gastrointestinal (GI) obstruction ( 4 , 5.6 ) • Bowel perforation ( 4 , 5.6 ) • Gastric retention ( 4 ) • Ileus ( 4 ) • Toxic colitis or toxic megacolon ( 4 ) • Hypersensitivity to any ingredient in MoviPrep ( 4 , 5.10 )
Pregnancy & Breastfeeding
8.1 Pregnancy Risk Summary There are no available data on MoviPrep in pregnant women to inform a drug-associated risk for adverse developmental outcomes. Animal reproduction studies have not been conducted with MoviPrep. The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.
2 interactions on record
Concurrent use with MoviPrep may increase risk of mucosal ulceration or ischemic colitis. Avoid use of stimulant laxatives while taking MoviPrep.
Source: NLP:polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate
Concurrent use with MoviPrep may increase risk of mucosal ulceration or ischemic colitis. Avoid use of stimulant laxatives while taking MoviPrep.
Source: NLP:polyethylene glycol 3350, sodium sulfate, sodium chloride, potassium chloride, ascorbic acid, sodium ascorbate